Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02697695
Other study ID # FF 145/2015
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 2014
Est. completion date February 2016

Study information

Verified date July 2018
Source Sana Klinikum Offenbach
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To evaluate the impact of obesity surgery on chronic inflammation.


Description:

A retrospective study to compare the impact of laparoscopic sleeve gastrectomy (LSG), laparoscopic Roux-en Y- gastric bypass (LRYGB) and laparoscopic omega-loop gastric bypass (LOLGB) on chronic inflammation and metabolic syndrome.


Recruitment information / eligibility

Status Completed
Enrollment 500
Est. completion date February 2016
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- BMI > 35kg/m² and obesity-related disease or BMI > 40kg/m²

Exclusion Criteria:

- acute inflammation during laboratory examination

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Laboratory Examination
Laboratory Examination before, 1 month, 3 month, 6 month and up to 12 month after LSK, LRNYGB, LOLGB

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sana Klinikum Offenbach

References & Publications (5)

Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004 Dec;114(12):1752-61. — View Citation

Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006 Dec 14;444(7121):860-7. Review. — View Citation

Morshed G, Fathy SM. Impact of post-laparoscopic sleeve gastrectomy weight loss on C-reactive protein, lipid profile and CA-125 in morbidly obese women. Wideochir Inne Tech Maloinwazyjne. 2016 Jan;10(4):521-6. doi: 10.5114/wiitm.2015.56480. Epub 2015 Dec — View Citation

Nijhuis J, Rensen SS, Slaats Y, van Dielen FM, Buurman WA, Greve JW. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring). 2009 Nov;17(11):2014-8. doi: 10.1038/oby.2009.113. Epub 2009 Apr 23. — View Citation

Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005 May;115(5):1111-9. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Chronic inflammation the changing of leucocytes in /nl after obesity surgery one day preoperatively, and 1 month, 3 month, 6 month and up to 12 month postoperatively
Secondary Fatty liver index the changing of fatty liver index after obesity surgery one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively
Secondary Liver enzymes the changing of GOT in U/l, GPT in U/l, GGT in U/l, AP in U/l after obesity surgery one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively
Secondary Body Mass Index (BMI) in kg/m² the changing of BMI in kg/m² before and after obesity surgery one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively
Secondary weight in kg the changing of weight before and after obesity surgery one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively
Secondary waist circumference the changing of waist circumference in cm before and after obesity surgery one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively
Secondary HbA1c the changing of HbA1c in % and after obesity surgery one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively
Secondary Chronic inflammation II the changing of c-reactive protein in mg/l after obesity surgery one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively
Secondary Acute inflammation the changing of c-reactive protein in mg/l after obesity surgery one day preoperatively and one and four days postoperatively
Secondary Acute inflammation II the changing of leucocytes in /nl after obesity surgery one day preoperatively and one and four days postoperatively
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2